2'-O-[2-(amino)-2-oxoethyl] oligonucleotides

Area of Science:

• Medicinal Chemistry
• Molecular Biology
• Biochemistry

Background:

• Oligonucleotides are crucial in molecular biology and therapeutics.
• Existing oligonucleotide chemistries face challenges with nuclease stability and target specificity.
• Developing modified oligonucleotides with improved properties is essential for advancing nucleic acid-based therapies.

Purpose of the Study:

• To synthesize and characterize novel oligonucleotide modifications.
• To evaluate the binding affinity of these modified oligonucleotides to RNA and DNA.
• To assess the nuclease stability of the modified oligonucleotides.

Main Methods:

• Chemical synthesis of four novel oligonucleotide modifications: 2'-O-[2-(amino)-2-oxoethyl] (2'-O-NAc), 2'-O-[2-(methylamino)-2-oxoethyl] (2'-O-NMAc), 2'-O-[2-(dimethylamino)-2-oxoethyl] (2'-O-DMAc), and 2'-O-[2-[[2-(dimethylamino)ethyl]amino]-2-oxoethyl] (2'-O-DMAEAc).
• Hybridization studies to determine binding affinity to complementary RNA and DNA sequences.
• Nuclease stability assays measuring the half-life (t(1/2)) of modified oligonucleotides.

Main Results:

• Successful synthesis of four novel oligonucleotide modifications.
• Demonstrated high binding affinity to complementary RNA sequences.
• Exhibited negligible binding affinity to DNA sequences.
• Significantly enhanced nuclease stability, with a half-life exceeding 24 hours (t(1/2) > 24 h).

Conclusions:

• The novel 2'-O-NAc, 2'-O-NMAc, 2'-O-DMAc, and 2'-O-DMAEAc modifications impart excellent nuclease resistance to oligonucleotides.
• These modifications confer high binding affinity and specificity for complementary RNA.
• The enhanced stability and RNA-selectivity suggest potential applications in nucleic acid-based therapeutics.